We are live on ! Find out more
AWH

Aspira Women's Health Inc. Common Stock

Delisted

AWH was delisted on the 16th of April, 2025.

1 hedge funds and large institutions have $0 invested in Aspira Women's Health Inc. Common Stock in 2025 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 11 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

100% less capital invested

Capital invested by funds: $392 → $0 (-$392)

Holders
1
Holders Change
Holders Change %
0%
% of All Funds
0.01%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
Reduced
Closed
1
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Osaic Holdings
Osaic Holdings
Arizona
-$392
Name Holding Trade Value Shares
Change
Change in
Stake
Osaic Holdings
1
Osaic Holdings
Arizona
-$392 -800 Closed

AWH Hedge Fund Activity: Q4 2025 in Review

1 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Aspira Women's Health Inc. Common Stock (AWH) for Q4 2025, worth a combined $0 — down 100% from $392 a quarter earlier.

Fund positioning in AWH was balanced in Q4 2025: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 0 trimmed.

The largest seller was Osaic Holdings, exiting entirely with an estimated $392 sold.

  • 1 institutional investor held Aspira Women's Health Inc. Common Stock (AWH) as of Q4 2025, unchanged from Q3 2025.
  • Funds reported $0 of Aspira Women's Health Inc. Common Stock stock for Q4 2025, down 100% quarter-over-quarter.
  • 1 fund opened new Aspira Women's Health Inc. Common Stock positions in Q4 2025 and 1 closed out, a net change of 0 holders.
  • The largest Aspira Women's Health Inc. Common Stock seller in Q4 2025 was Osaic Holdings, an estimated $392 sold.

Based on aggregated 13F filings for Q4 2025.